Algal-based anesthetic partnership at Boston Children’s Hospital

Grünenthal Group, an international, family-owned pharmaceutical company, Proteus S.A. and Boston Children’s Hospital have announced a collaboration around developing neosaxitoxin, a novel anesthetic for local anesthesia and post-operative pain management. The deal includes up to $85…

Read More